RNS Number:4329C
Medisys PLC
04 May 2006


For Immediate Release                                                 4 May 2006

                                  Medisys PLC
                          ("Medisys" or "the Company")
                                        
                                  EGM Statement

Medisys PLC held an  Extraordinary General Meeting today and the Board is 
pleased to announce that the resolution to approve the disposal to Arkray Inc. 
of the whole of its operating businesses comprising primarily its Blood Glucose 
Monitoring business (the "Disposal") for a consideration of $42.8 million 
(approximately #24.2 million) in cash, was duly passed by shareholders.  The 
Disposal is due to be completed on 11 May 2006.

Dr. David Wong, Executive Chairman commented:

"The approval today for the disposal of our Blood Glucose Monitoring business
allows us to realise significant value for our shareholders and for Medisys to
progress debt free.

"The Company is now positioned as a focused investment company intending to
invest in companies with strong niche market positions in the areas of medical
devices, diagnostics, biopharmaceuticals and healthcare, where we believe
significant investment and co-investment opportunities exist. The Board will be
making a further announcement in due course."

                                    - Ends -

Enquiries:

Medisys PLC
David Wong, Chairman                                               01394 446 717
Jonathan Chapman, Company Secretary

Weber Shandwick Square Mile
John Moriarty                                                      020 7067 0700






                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
EGMILFILEEISIIR
MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jun 2024 bis Jul 2024 Click Here for more MDY Healthcare Charts.
MDY Healthcare (LSE:MDY)
Historical Stock Chart
Von Jul 2023 bis Jul 2024 Click Here for more MDY Healthcare Charts.